Brief: Lidds Broadens Scope Of Its Technology Platform By Verifying Nanozoli® As Subcutaneous Depot For Systemic Delivery

Lidds AB

15/05/2018 07:41

May 15 (Reuters) - LIDDS AB  LIDDS.ST :
    * REG-LIDDS BROADENS THE SCOPE OF ITS TECHNOLOGY PLATFORM BY
VERIFYING NANOZOLID® AS SUBCUTANEOUS DEPOT FOR SYSTEMIC DELIVERY
    * NEW FINDINGS COMPLEMENT NANOZOLID® PLATFORM THAT IS WELL
VERIFIED FOR INTRATUMORAL DELIVERY OF DRUGS.

Source text for Eikon:  ID:nGNE3D6wxq 
Further company coverage:  LIDDS.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 587720920;))